Maintenance of Remission with Etanercept–DMARD Combination Therapy Compared with DMARDs Alone in African and Middle Eastern Patients with Active Rheumatoid Arthritis
Crossref DOI link: https://doi.org/10.1007/s40744-018-0094-6
Published Online: 2018-02-26
Published Print: 2018-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Bassiouni, Hassan
Spargo, Catherine Elizabeth
Vlahos, Bonnie
Jones, Heather E.
Pedersen, Ron
Shirazy, Khalid
Funding for this research was provided by:
Pfizer
Text and Data Mining valid from 2018-02-26
Article History
Received: 31 October 2017
First Online: 26 February 2018